Antiprogestin method and kit for reducing side effects associated with low dosage HRT, oral contraception and regulating menses
US7538099B1 · kind B1 · utility
0Cited by
13References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 1995 |
| Grant date | May 26, 2009 |
| Priority date | — |
| Expiry date | Jun 5, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Menses regulation and, when desired, contraception is achieved at low doses of estrogen and progestin, which otherwise would create episodes of breakthrough bleeding and/or withdrawal amenorrhea, by periodically inducing menses with an antiprogestin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.